• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国糖尿病患者的药物费用相关不依从性。

Cost-related medication non-adherence among U.S. adults with diabetes.

机构信息

Department of Systems and Information Engineering, School of Engineering, University of Virginia, Charlottesville, VA, United States.

Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, VA, United States.

出版信息

Diabetes Res Clin Pract. 2018 Sep;143:24-33. doi: 10.1016/j.diabres.2018.06.016. Epub 2018 Jun 23.

DOI:10.1016/j.diabres.2018.06.016
PMID:29944967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6204232/
Abstract

AIMS

To examine factors that affect cost-related medication non-adherence (CRN), defined as taking medication less than as prescribed because of cost, among adults with diabetes and to determine their relative contribution in explaining CRN.

METHODS

Behavioral Risk Factor Surveillance System data for 2013-2014 were used to identify individuals with diabetes and their CRN. We modeled CRN as a function of financial factors, regimen complexity, and other contextual factors including diabetes care, lifestyle, and health factors. Dominance analysis was performed to rank these factors by relative importance.

RESULTS

CRN among U.S. adults with diabetes was 16.5%. Respondents with annual income <$50,000 and without health insurance were more likely to report CRN, compared to those with income ≥$50,000 and those with insurance, respectively. Insulin users had 1.24 times higher risk of CRN compared to those not on insulin. Contextual factors that significantly affected CRN included diabetes care factors, lifestyle factors, and comorbid depression, arthritis, and COPD/asthma. Dominance analysis showed health insurance was the most important factor for respondents <65 and depression was the most important factor for respondents ≥65.

CONCLUSIONS

In addition to traditional risk factors of CRN, compliance with annual recommendations for diabetes and healthy lifestyle were associated with lower CRN. Policies and social supports that address these contextual factors may help improve CRN.

摘要

目的

研究影响糖尿病患者药物费用相关不依从性(CRN)的因素,即由于费用原因而未按规定服用药物,并确定这些因素在解释 CRN 方面的相对贡献。

方法

利用 2013-2014 年行为风险因素监测系统的数据,确定患有糖尿病的个体及其 CRN。我们将 CRN 建模为财务因素、治疗方案复杂性以及包括糖尿病护理、生活方式和健康因素在内的其他背景因素的函数。采用优势分析对这些因素进行相对重要性排序。

结果

美国糖尿病成年患者的 CRN 为 16.5%。与收入≥$50,000 且有保险的患者相比,年收入<$50,000 且没有保险的患者更有可能报告 CRN。与未使用胰岛素的患者相比,使用胰岛素的患者发生 CRN 的风险高 1.24 倍。对 CRN 有显著影响的背景因素包括糖尿病护理因素、生活方式因素以及并发抑郁、关节炎和 COPD/哮喘。优势分析表明,对于 65 岁以下的患者,医疗保险是最重要的因素,而对于 65 岁及以上的患者,抑郁是最重要的因素。

结论

除了 CRN 的传统风险因素外,遵守年度糖尿病建议和健康生活方式与较低的 CRN 相关。解决这些背景因素的政策和社会支持可能有助于改善 CRN。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2662/6204232/e3cce3dd0ff7/nihms-991991-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2662/6204232/e3cce3dd0ff7/nihms-991991-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2662/6204232/e3cce3dd0ff7/nihms-991991-f0001.jpg

相似文献

1
Cost-related medication non-adherence among U.S. adults with diabetes.美国糖尿病患者的药物费用相关不依从性。
Diabetes Res Clin Pract. 2018 Sep;143:24-33. doi: 10.1016/j.diabres.2018.06.016. Epub 2018 Jun 23.
2
Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.评估与老年美国医疗保险受益人药物费用相关不依从相关因素的重要性。
Drugs Aging. 2019 Dec;36(12):1111-1121. doi: 10.1007/s40266-019-00715-3.
3
Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013-2018.美国成年人糖尿病患者的与费用相关的药物不依从性:2013-2018 年全国健康访谈调查。
Diabetes Care. 2022 Mar 1;45(3):594-603. doi: 10.2337/dc21-1757.
4
Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.医疗保险处方药计划中糖尿病患者药物种类相关用药不依从性。
Med Care. 2013 Feb;51(2):193-8. doi: 10.1097/MLR.0b013e318270dc52.
5
Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older With Chronic Diseases.65 岁及以上患有慢性病的成年人的态度、信念和与费用相关的药物不依从性。
Prev Chronic Dis. 2018 Dec 6;15:E148. doi: 10.5888/pcd15.180190.
6
Cost-related medication nonadherence among over-indebted individuals enrolled in statutory health insurance in Germany: a cross-sectional population study.德国法定健康保险中负债人群的与费用相关的药物不依从性:一项横断面人群研究。
BMC Health Serv Res. 2019 Nov 26;19(1):887. doi: 10.1186/s12913-019-4710-0.
7
Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases.美国慢性肝病患者药物费用相关不依从性。
Mayo Clin Proc. 2021 Oct;96(10):2639-2650. doi: 10.1016/j.mayocp.2021.02.026. Epub 2021 Jun 11.
8
Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.老年医疗保险计划 D 受益人中自付费用增加和品牌口服抗糖尿病药物依从性降低。
J Gen Intern Med. 2013 Jul;28(7):876-85. doi: 10.1007/s11606-013-2342-3. Epub 2013 Feb 13.
9
Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension.报告显示,在患有冠心病、糖尿病和/或高血压的老年患者中,药物不依从的发生率及其相关因素。
Res Social Adm Pharm. 2013 Nov-Dec;9(6):817-27. doi: 10.1016/j.sapharm.2012.12.002. Epub 2013 Jan 4.
10
Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.癌症幸存者中与费用相关的药物不依从的种族和民族差异。
J Cancer Surviv. 2016 Jun;10(3):534-44. doi: 10.1007/s11764-015-0499-y. Epub 2015 Nov 30.

引用本文的文献

1
Longitudinal progression of cost-related medication non-adherence among Medicare patients with diabetes at high risk of hospitalization: The role of dual eligibility.糖尿病住院高风险医疗保险患者中与费用相关的药物治疗不依从性的纵向进展:双重资格的作用
PLoS One. 2025 Aug 14;20(8):e0329031. doi: 10.1371/journal.pone.0329031. eCollection 2025.
2
The impact of self-care training using the teach-back method with telephone follow-up on adherence to treatment in patients with hypothyroidism: a randomized controlled clinical trial.采用回授法并通过电话随访进行自我护理培训对甲状腺功能减退症患者治疗依从性的影响:一项随机对照临床试验。
BMC Health Serv Res. 2025 Jun 2;25(1):781. doi: 10.1186/s12913-025-12962-9.
3

本文引用的文献

1
Insulin Access and Affordability Working Group: Conclusions and Recommendations.胰岛素可及性与可负担性工作组:结论与建议
Diabetes Care. 2018 Jun;41(6):1299-1311. doi: 10.2337/dci18-0019. Epub 2018 May 8.
2
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.美国临床内分泌医师协会和美国内分泌学会关于2型糖尿病综合管理算法(2017年执行摘要)的共识声明。
Endocr Pract. 2017 Feb;23(2):207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17.
3
Adherence to Insulin Therapy.
The Burden of Comorbid Depression and Type 2 Diabetes: An Empirical Study Using Commercial Insurance Data.
共病抑郁症和2型糖尿病的负担:一项使用商业保险数据的实证研究。
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251336629. doi: 10.1177/21501319251336629. Epub 2025 May 8.
4
Disparities in Antidiabetic Medication Discontinuation Between Non-Hispanic White and Black Beneficiaries in Medicare Across Diabetes Belt and Surrounding Area.医疗保险中,非西班牙裔白人和黑人受益人群在糖尿病带及周边地区抗糖尿病药物停药情况的差异。
J Racial Ethn Health Disparities. 2025 Mar 15. doi: 10.1007/s40615-025-02388-8.
5
Evaluating Financial Incentives as a Tool to Increase Medication Adherence for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.评估经济激励措施作为提高2型糖尿病患者药物依从性的工具:一项系统评价和荟萃分析。
Diabetes Ther. 2025 Mar;16(3):527-545. doi: 10.1007/s13300-025-01694-y. Epub 2025 Feb 10.
6
Stakeholder perspectives on facilitators and barriers to implementing a zero-dollar copay program for chronic conditions study.利益相关者对实施慢性病零自付计划的促进因素和障碍的看法研究。
Health Res Policy Syst. 2025 Jan 6;23(1):6. doi: 10.1186/s12961-024-01278-5.
7
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025.9. 血糖治疗的药理学方法:2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S181-S206. doi: 10.2337/dc25-S009.
8
Cost-Related Medication Behaviors for Patients With and Without Systemic Autoimmune Rheumatic Diseases.患有和未患有系统性自身免疫性风湿病患者的费用相关用药行为
Arthritis Care Res (Hoboken). 2025 Apr;77(4):545-555. doi: 10.1002/acr.25442. Epub 2024 Oct 27.
9
Racial and Ethnic Differences in Diabetes Care Quality in A National Sample of Cancer Survivors Relative to Non-Cancer Controls.全国癌症幸存者样本与非癌症对照人群在糖尿病护理质量方面的种族和民族差异。
J Racial Ethn Health Disparities. 2024 Sep 4. doi: 10.1007/s40615-024-02156-0.
10
Health Outcome Changes in Individuals With Type 1 Diabetes After a State-Level Insulin Copayment Cap.州级胰岛素共付额上限对 1 型糖尿病患者健康结局的影响。
JAMA Netw Open. 2024 Aug 1;7(8):e2425280. doi: 10.1001/jamanetworkopen.2024.25280.
胰岛素治疗的依从性。
Diabetes Spectr. 2016 Aug;29(3):166-70. doi: 10.2337/diaspect.29.3.166.
4
Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study.药物治疗方案复杂性和多重用药作为老年人全因死亡率相关因素:一项基于人群的队列研究。
Ann Pharmacother. 2016 Feb;50(2):89-95. doi: 10.1177/1060028015621071. Epub 2015 Dec 17.
5
Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.癌症幸存者中与费用相关的药物不依从的种族和民族差异。
J Cancer Surviv. 2016 Jun;10(3):534-44. doi: 10.1007/s11764-015-0499-y. Epub 2015 Nov 30.
6
Gender differences in cost-related medication non-adherence among cancer survivors.癌症幸存者中与费用相关的药物治疗不依从性的性别差异。
J Cancer Surviv. 2016 Apr;10(2):384-93. doi: 10.1007/s11764-015-0484-5. Epub 2015 Sep 9.
7
Medicare Part D coverage gap: race, gender, and cost-related medication nonadherence.医疗保险D部分覆盖缺口:种族、性别与费用相关的药物治疗不依从性
Soc Work Public Health. 2015;30(6):473-85. doi: 10.1080/19371918.2015.1052607. Epub 2015 Aug 6.
8
Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.接受西他列汀或磺脲类药物联合二甲双胍双重治疗的2型糖尿病患者进展至胰岛素治疗的情况。
Diabetes Obes Metab. 2015 Oct;17(10):956-64. doi: 10.1111/dom.12489. Epub 2015 Jun 22.
9
Poor medication adherence in diabetes: What's the problem?糖尿病患者用药依从性差:问题出在哪里?
J Diabetes. 2015 Nov;7(6):777-8. doi: 10.1111/1753-0407.12306. Epub 2015 Jun 9.
10
Risk factors for cost-related medication non-adherence among older patients with diabetes.老年糖尿病患者中与费用相关的药物治疗不依从的风险因素。
World J Diabetes. 2014 Dec 15;5(6):945-50. doi: 10.4239/wjd.v5.i6.945.